Purchase Order 75D30122P13251
Award Date 2/11/22
Potential Completion Date 2/13/23
Potential Value $79K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Ann Arbor, MI 48108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) awarded a $1.2 million definitive contract to Genomenon Inc. on September 12, 2023, for the provision of professional licenses and application programming interface (API) access to the company's Mastermind Genomic search engine and literature curation platform. The contract, which carries no set-aside designation and is structured as a firm fixed-price agreement, encompasses 45 professional licenses and API token access to support the...
- This federal contract award, with ID HHSD2002016M90832P, was made by the Centers for Disease Control and Prevention (CDC) to Genologics Life Sciences Software Inc. The $113,422.00 Firm Fixed Price purchase order is for software licenses and support, with a period of performance ending on August 16, 2020. The contract does not have a set-aside designation. Genologics Life Sciences Software Inc. is a for-profit organization that was awarded this federal contract but does not appear to have any...
- This is a federal purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Genologics Life Sciences Software Inc. for software maintenance services for the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID). The contract has a firm fixed price of $136,030.00 and a period of performance from February 17, 2017 to August 16, 2019. The contract does not have a set-aside designation. Genologics Life Sciences Software Inc. is the prime...
- This is a federal contract award to 10X Genomics, Inc., a life sciences technology company, by the Centers for Disease Control and Prevention (CDC). The $75,072 firm fixed-price contract is for the provision of goods and services related to 10X Genomics' genomic analysis platforms, reagents, instruments, and bioinformatics software. These products and services support single-cell and spatial analysis applications, enabling high-throughput interrogation of biological systems at the single-cell...
- This is a $25,000 cost-plus-fixed-fee delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Massgenics Inc., a minority-owned management consulting firm that specializes in providing international technical, operational, and professional support services. The contract is part of the CDC's ITOPSS 4.0 program, a multiple-award Indefinite Delivery Contract (IDC) with a $45 million ceiling that enables the CDC to quickly issue task orders for global health...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to 10X Genomics, Inc., a for-profit life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The contract, with a ceiling value of $75,114.00, is for the delivery of laboratory instruments. The contract type is a firm fixed price purchase order with an ultimate completion date of August 1, 2015. The contract...
- 10X Genomics, Inc., doing business as 10X Genomics, has been awarded a firm fixed price purchase order valued at $249,649.15 by the Centers for Disease Control and Prevention (CDC) to provide single-cell RNA-seq library preparation services. The purpose of this contract is to support CDC's efforts to study the host immune response induced by influenza vaccines through transcriptomic analysis at the single-cell level. Performance will take place in Atlanta, Georgia over a two week period...
- This is a $2,363,639.66 cost-plus-fixed-fee delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Massgenics Inc., a minority-owned, for-profit management consulting firm that is a division of Innova Solutions, Inc. The contract, which is not set aside, is for professional support services under the CDC's International Technical, Operational and Professional Support Services III (ITOPSS III) multiple-award Indefinite Delivery Contract (IDC) vehicle. The scope...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a maintenance agreement with a total ceiling value of $75,716.00 and a period of performance through June 10, 2021. The contract does not have a set-aside designation. Illumina has previously received prime federal contracts and subcontracts from agencies such as the...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Genomenon Inc., a small disadvantaged business, for software licensing. The $78,500 contract has an ultimate completion date of February 13, 2023. Genomenon will provide access to its Mastermind Genomic search engine and literature curation solution to support the CDC's National Newborn Screening Data Platform. This contract builds on Genomenon's prior work with the CDC and National Institutes of Health (NIH) to leverage the company's genomic database and interpretation capabilities for diagnostic and therapeutic applications. The contract does not have a set-aside designation.
Generated 4/3/25, 2:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $78.5k | 2/11/22 |